These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8071398)

  • 21. Stability of Diazoxide in Extemporaneously Compounded Oral Suspensions.
    Friciu M; Zaraa S; Roullin VG; Leclair G
    PLoS One; 2016; 11(10):e0164577. PubMed ID: 27727306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stability Studies of a Freeze-Dried Recombinant Human Epidermal Growth Factor Formulation for Wound Healing.
    Santana H; García G; Vega M; Beldarraín A; Páez R
    PDA J Pharm Sci Technol; 2015; 69(3):399-416. PubMed ID: 26048746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crosslinking studies in gelatin capsules treated with formaldehyde and in capsules exposed to elevated temperature and humidity.
    Ofner CM; Zhang YE; Jobeck VC; Bowman BJ
    J Pharm Sci; 2001 Jan; 90(1):79-88. PubMed ID: 11064381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stability of tacrolimus in an extemporaneously compounded oral liquid.
    Jacobson PA; Johnson CE; West NJ; Foster JA
    Am J Health Syst Pharm; 1997 Jan; 54(2):178-80. PubMed ID: 9117806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Soft gelatin capsules II: Oxygen permeability study of capsule shells.
    Hom FS; Veresh SA; Ebert WR
    J Pharm Sci; 1975 May; 64(5):851-7. PubMed ID: 1151660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stability of dantrolene oral suspension prepared from capsules.
    Fawcett JP; Stark G; Tucker IG; Woods DJ
    J Clin Pharm Ther; 1994 Dec; 19(6):349-53. PubMed ID: 7876365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The chemical stability of captopril capsules.
    Colucci RD; Auty R; Scavone J; Glassner-Cohen L
    Int J Clin Pharmacol Ther Toxicol; 1989 Dec; 27(12):599-601. PubMed ID: 2693375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro stability of lyophilized and reconstituted recombinant activated factor VII formulated for storage at room temperature.
    Nedergaard H; Vestergaard S; Jensen PT; Kristiansen MW; Jensen MB; Ostergaard PB; Norsell T; Bjerre J
    Clin Ther; 2008 Jul; 30(7):1309-15. PubMed ID: 18691990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stability of isradipine in an extemporaneously compounded oral liquid.
    MacDonald JL; Johnson CE; Jacobson P
    Am J Hosp Pharm; 1994 Oct; 51(19):2409-11. PubMed ID: 7847406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stability of ranitidine syrup re-packaged in unit-dose containers.
    Shah RB; Prasanna HR; Rothman B; Khan MA
    Am J Health Syst Pharm; 2008 Feb; 65(4):325-9. PubMed ID: 18238770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stability of ursodiol in an extemporaneously compounded oral liquid.
    Johnson CE; Nesbitt J
    Am J Health Syst Pharm; 1995 Aug; 52(16):1798-1800. PubMed ID: 8528836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stability of famotidine in an extemporaneously prepared oral liquid.
    Quercia RA; Jay GT; Fan C; Chow MS
    Am J Hosp Pharm; 1993 Apr; 50(4):691-3. PubMed ID: 8470686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stability of omeprazole in an extemporaneously prepared oral liquid.
    Quercia RA; Fan C; Liu X; Chow MS
    Am J Health Syst Pharm; 1997 Aug; 54(16):1833-6. PubMed ID: 9269520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suspensions as a Valuable Alternative to Extemporaneously Compounded Capsules.
    Dijkers E; Nanhekhan V; Thorissen A; Polonini H
    Int J Pharm Compd; 2017; 21(2):171-175. PubMed ID: 28346214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of an extemporaneous liquid formulation of lisinopril.
    Thompson KC; Zhao Z; Mazakas JM; Beasley CA; Reed RA; Moser CL
    Am J Health Syst Pharm; 2003 Jan; 60(1):69-74. PubMed ID: 12533979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stability of norfloxacin in an extemporaneously prepared oral liquid.
    Johnson CE; Price J; Hession JM
    Am J Health Syst Pharm; 2001 Apr; 58(7):577-9. PubMed ID: 11296605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nifedipine capsules may provide a viable alternative to oral powders for paediatric patients.
    Helin-Tanninen M; Naaranlahti T; Kontra K; Savolainen K
    J Clin Pharm Ther; 2007 Feb; 32(1):49-55. PubMed ID: 17286789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A study on gelatin capsule brittleness: moisture tranfer between the capsule shell and its content.
    Chang RK; Raghavan KS; Hussain MA
    J Pharm Sci; 1998 May; 87(5):556-8. PubMed ID: 9572904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stability of gabapentin 300-mg capsules repackaged in unit dose containers.
    Gupta A; Ciavarella AB; Rothman B; Faustino PJ; Khan MA
    Am J Health Syst Pharm; 2009 Aug; 66(15):1376-80. PubMed ID: 19635774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The fixed combination of propranolol and bendrofluazide in the treatment of hypertension.
    Jäättelä A
    Ann Clin Res; 1979 Apr; 11(2):80-2. PubMed ID: 378094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.